![Neurology Live](https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/010/808/normal/Screenshot_2023-01-16_101310.png?1673864062)
Clinical Trial Design in Alzheimer’s Disease Research
Neurology Live,
Sponsored by Eisai Inc. and Biogen The Alzheimer’s disease research and clinical trial landscape has never been so exciting.
Sponsored by Eisai Inc. and Biogen The Alzheimer’s disease research and clinical trial landscape has never been so exciting.
Alzheimer's disease (AD) is a neurogenerative disorder marked by cognitive and behavioral impairment.
Summary The FDA has approved Eisai Co.'s Leqembi label last week, developed with Biogen, for the potential treatment of adult…
Alzheimer's disease (AD) is often seen with a wide range of comorbid diseases that are also more common in older individuals.